IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.180
+0.020 (0.93%)
At close: Jul 3, 2025, 1:00 PM
2.160
-0.020 (-0.92%)
After-hours: Jul 3, 2025, 4:57 PM EDT
IN8bio Stock Forecast
INAB's stock price has decreased by -91.01% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover IN8bio stock have a consensus rating of "Strong Buy" and an average price target of $108, which forecasts a 4854.13% increase in the stock price over the next year. The lowest target is $36 and the highest is $180.
Price Target: $108 (+4854.13%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 14, 2025.
Analyst Ratings
The average analyst rating for IN8bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $240 → $180 | Strong Buy | Maintains | $240 → $180 | +8,156.88% | Mar 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +10,909.17% | Feb 12, 2025 |
Jones Trading | Jones Trading | Hold → Strong Buy Upgrades $36 | Hold → Strong Buy | Upgrades | $36 | +1,551.38% | Feb 11, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +10,909.17% | Nov 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $375 → $240 | Strong Buy | Maintains | $375 → $240 | +10,909.17% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
n/a
from 88.41M
Revenue Next Year
n/a
EPS This Year
-6.43
from -17.05
EPS Next Year
-6.27
from -6.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 8.4M | ||
Avg | n/a | n/a | 2.7M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -5.35 | -5.67 | -3.78 | ||
Avg | -6.43 | -6.27 | -5.92 | ||
Low | -7.06 | -7.35 | -8.82 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.